alexa Detection And Evaluation Of Drug Safety Signals In Post Marketing Phase | 22920
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials

Neha Vala
ScientificTracks Abstracts: J Pharmacovigilance
DOI: 10.4172/2329-6887.S1.012
Abstract
The safety of all the medicinal products needs to be monitored throughout the product life cycle. The primary function of pharmacovigilance is to detect early warnings (potential signals) with regard to Adverse Drug Reactions which were previously unknown or unquantified. The concept of a drug safety signal is not new. Indeed, it has been the cornerstone of pharmacovigilance activities for about forty years. However, as more medicines are authorised for marketing each year, and as increasing numbers of persons are taking medicines this has resulted in an increase in the number of adverse events reported to manufacturers and to regulators. The life cycle of drug safety signal includes signal detection, signal prioritization and signal evaluation. If the evaluation of a drug safety signal establishes a new Adverse Drug Reaction, then this stage of the signal?s life cycle will lead to an update of the product?s prescribing information and, possibly, other regulatory actions including further risk communications and risk minimisation efforts. There are different methods for signal detection which include traditional methods (qualitative) and data mining methods (quantative). The manual review of paper based reports that provided the foundation of early productive pharmacovigilance systems is simply no longer practical. Modern pharmacovigilance systems, which received several hundred thousand reports each year and which have databases containing several million adverse event reports, must be able to detect, prioritize and evaluate signals in an efficient and proactive manner. To do so requires a systematic approach that couples statistical and analytic methods with sound clinical judgement.
Biography
Neha Vala is an MBBS doctor with 9 years of clinical experience including 5 years in Pharmacovigilance domain, having key expertise in signal detection and risk management activity. Currently, she is working as Operations Manager in pharmacovigilance department of Lambda Therapeutic Research Limited and handling different teams of case processing, aggregate reports, risk management, signal detection, medical review, submission and medical information system. She has also handled multiple regulatory and client audits successfully.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7